US Stock MarketDetailed Quotes

Jazz Pharmaceuticals (JAZZ)

Watchlist
  • 232.330
  • +4.490+1.97%
Close May 13 15:59 ET
  • 231.010
  • -1.320-0.57%
Pre 04:25 ET
14.58BMarket Cap2112.09P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jazz Pharmaceuticals (JAZZ) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
19.06%1.07B
4.88%4.27B
10.09%1.2B
6.74%1.13B
2.14%1.05B
-0.46%897.8M
6.12%4.07B
7.53%1.09B
8.52%1.05B
6.95%1.02B
Operating revenue
19.06%1.07B
4.88%4.27B
10.09%1.2B
6.74%1.13B
2.14%1.05B
-0.46%897.8M
6.12%4.07B
7.53%1.09B
8.52%1.05B
6.95%1.02B
Cost of revenue
28.20%134.1M
12.92%503.3M
19.28%153.53M
15.47%128.88M
5.79%116.27M
9.54%104.6M
2.33%445.71M
20.02%128.71M
9.26%111.61M
12.68%109.9M
Gross profit
17.85%934.8M
3.89%3.76B
8.85%1.04B
5.71%997.23M
1.70%929.44M
-1.65%793.2M
6.61%3.62B
6.05%959.46M
8.43%943.36M
6.30%913.92M
Operating expense
-29.55%598.2M
12.09%3.25B
2.75%789.86M
31.34%897.22M
-0.56%710.47M
16.27%849.1M
3.41%2.9B
0.59%768.69M
-2.07%683.15M
1.76%714.48M
Selling and administrative expenses
-31.38%352.7M
30.61%1.81B
10.00%406.21M
62.89%530.65M
5.87%358.4M
46.14%514M
3.14%1.39B
-6.75%369.29M
5.66%325.77M
-0.68%338.52M
Research and development costs
8.47%196M
-11.46%782.74M
-11.06%213.91M
-0.86%198.2M
-13.94%189.97M
-18.91%180.7M
4.04%884M
11.03%240.5M
-14.71%199.92M
5.49%220.73M
Depreciation amortization depletion
11.59%172.3M
4.36%654.66M
6.82%169.74M
6.93%168.37M
4.43%162.1M
-0.85%154.4M
3.13%627.31M
4.85%158.9M
1.66%157.46M
2.08%155.22M
-Depreciation and amortization
11.59%172.3M
4.36%654.66M
6.82%169.74M
6.93%168.37M
4.43%162.1M
-0.85%154.4M
3.13%627.31M
4.85%158.9M
1.66%157.46M
2.08%155.22M
Other operating expenses
---122.8M
----
----
----
----
----
----
----
----
----
Operating profit
702.15%336.6M
-28.76%517.62M
33.43%254.54M
-61.57%100.01M
9.79%218.97M
-173.35%-55.9M
21.60%726.63M
35.78%190.77M
50.94%260.21M
26.52%199.44M
Net non-operating interest income expense
25.70%-39.9M
18.08%-195.05M
11.41%-45.41M
17.25%-48.58M
23.64%-47.36M
18.78%-53.7M
17.74%-238.1M
27.11%-51.26M
17.90%-58.7M
15.58%-62.02M
Non-operating interest expense
-25.70%39.9M
-18.08%195.05M
-11.41%45.41M
-17.25%48.58M
-23.64%47.36M
-18.78%53.7M
-17.74%238.1M
-27.11%51.26M
-17.90%58.7M
-15.58%62.02M
Other net income (expense)
1,350.00%2.5M
-5,127.31%-950.43M
89.55%-658K
-5,948.22%-42.4M
-179,027.22%-907.16M
98.29%-200K
-78.03%-18.18M
27.20%-6.3M
49.09%-701K
121.28%507K
Gain on sale of security
1,350.00%2.5M
68.61%-2.57M
89.55%-658K
114.55%102K
-454.83%-1.8M
88.19%-200K
-193.11%-8.18M
-167.30%-6.3M
49.09%-701K
121.28%507K
Special income (charges)
----
-9,378.62%-947.86M
--0
---42.5M
---905.36M
--0
47.37%-10M
--0
--0
--0
-Less:Impairment of capital assets
----
----
----
----
----
----
--0
----
----
----
-Less:Other special charges
----
9,378.62%947.86M
--0
--42.5M
--905.36M
----
-47.37%10M
--0
----
----
Income before tax
372.50%299.2M
-233.49%-627.86M
56.49%208.47M
-95.50%9.04M
-633.29%-735.55M
-6,753.93%-109.8M
57.87%470.35M
116.52%133.22M
101.78%200.81M
68.65%137.93M
Income tax
134.27%6.1M
-197.98%-272.44M
108.57%4.96M
-1,568.09%-242.42M
43.99%-17.17M
-252.54%-17.8M
23.75%-91.43M
-75.02%-57.91M
69.19%-14.53M
-26.02%-30.65M
Earnings from equity interest net of tax
--0
55.90%-732K
-256.25%-57K
83.51%-47K
-616.67%-86K
62.88%-500K
44.83%-1.66M
96.53%-16K
-326.19%-285K
99.28%-12K
Net income
416.86%293.1M
-163.58%-356.15M
6.45%203.45M
16.91%251.41M
-526.22%-718.47M
-532.78%-92.5M
35.02%560.12M
102.98%191.12M
46.48%215.06M
61.40%168.57M
Net income continuous Operations
416.86%293.1M
-163.58%-356.15M
6.45%203.45M
16.91%251.41M
-526.22%-718.47M
-532.78%-92.5M
35.02%560.12M
102.98%191.12M
46.48%215.06M
61.40%168.57M
Minority interest income
Net income attributable to the parent company
416.86%293.1M
-163.58%-356.15M
6.45%203.45M
16.91%251.41M
-526.22%-718.47M
-532.78%-92.5M
35.02%560.12M
102.98%191.12M
46.48%215.06M
61.40%168.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
416.86%293.1M
-163.58%-356.15M
6.45%203.45M
16.91%251.41M
-526.22%-718.47M
-532.78%-92.5M
35.02%560.12M
102.98%191.12M
46.48%215.06M
61.40%168.57M
Basic earnings per share
411.18%4.73
-164.46%-5.84
5.38%3.33
18.29%4.14
-538.06%-11.74
-560.87%-1.52
38.32%9.06
110.67%3.16
50.21%3.5
64.42%2.68
Diluted earnings per share
391.45%4.43
-167.51%-5.84
3.22%3.21
19.30%4.08
-571.49%-11.74
-560.87%-1.52
41.80%8.65
119.01%3.11
59.81%3.42
63.82%2.49
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 19.06%1.07B4.88%4.27B10.09%1.2B6.74%1.13B2.14%1.05B-0.46%897.8M6.12%4.07B7.53%1.09B8.52%1.05B6.95%1.02B
Operating revenue 19.06%1.07B4.88%4.27B10.09%1.2B6.74%1.13B2.14%1.05B-0.46%897.8M6.12%4.07B7.53%1.09B8.52%1.05B6.95%1.02B
Cost of revenue 28.20%134.1M12.92%503.3M19.28%153.53M15.47%128.88M5.79%116.27M9.54%104.6M2.33%445.71M20.02%128.71M9.26%111.61M12.68%109.9M
Gross profit 17.85%934.8M3.89%3.76B8.85%1.04B5.71%997.23M1.70%929.44M-1.65%793.2M6.61%3.62B6.05%959.46M8.43%943.36M6.30%913.92M
Operating expense -29.55%598.2M12.09%3.25B2.75%789.86M31.34%897.22M-0.56%710.47M16.27%849.1M3.41%2.9B0.59%768.69M-2.07%683.15M1.76%714.48M
Selling and administrative expenses -31.38%352.7M30.61%1.81B10.00%406.21M62.89%530.65M5.87%358.4M46.14%514M3.14%1.39B-6.75%369.29M5.66%325.77M-0.68%338.52M
Research and development costs 8.47%196M-11.46%782.74M-11.06%213.91M-0.86%198.2M-13.94%189.97M-18.91%180.7M4.04%884M11.03%240.5M-14.71%199.92M5.49%220.73M
Depreciation amortization depletion 11.59%172.3M4.36%654.66M6.82%169.74M6.93%168.37M4.43%162.1M-0.85%154.4M3.13%627.31M4.85%158.9M1.66%157.46M2.08%155.22M
-Depreciation and amortization 11.59%172.3M4.36%654.66M6.82%169.74M6.93%168.37M4.43%162.1M-0.85%154.4M3.13%627.31M4.85%158.9M1.66%157.46M2.08%155.22M
Other operating expenses ---122.8M------------------------------------
Operating profit 702.15%336.6M-28.76%517.62M33.43%254.54M-61.57%100.01M9.79%218.97M-173.35%-55.9M21.60%726.63M35.78%190.77M50.94%260.21M26.52%199.44M
Net non-operating interest income expense 25.70%-39.9M18.08%-195.05M11.41%-45.41M17.25%-48.58M23.64%-47.36M18.78%-53.7M17.74%-238.1M27.11%-51.26M17.90%-58.7M15.58%-62.02M
Non-operating interest expense -25.70%39.9M-18.08%195.05M-11.41%45.41M-17.25%48.58M-23.64%47.36M-18.78%53.7M-17.74%238.1M-27.11%51.26M-17.90%58.7M-15.58%62.02M
Other net income (expense) 1,350.00%2.5M-5,127.31%-950.43M89.55%-658K-5,948.22%-42.4M-179,027.22%-907.16M98.29%-200K-78.03%-18.18M27.20%-6.3M49.09%-701K121.28%507K
Gain on sale of security 1,350.00%2.5M68.61%-2.57M89.55%-658K114.55%102K-454.83%-1.8M88.19%-200K-193.11%-8.18M-167.30%-6.3M49.09%-701K121.28%507K
Special income (charges) -----9,378.62%-947.86M--0---42.5M---905.36M--047.37%-10M--0--0--0
-Less:Impairment of capital assets --------------------------0------------
-Less:Other special charges ----9,378.62%947.86M--0--42.5M--905.36M-----47.37%10M--0--------
Income before tax 372.50%299.2M-233.49%-627.86M56.49%208.47M-95.50%9.04M-633.29%-735.55M-6,753.93%-109.8M57.87%470.35M116.52%133.22M101.78%200.81M68.65%137.93M
Income tax 134.27%6.1M-197.98%-272.44M108.57%4.96M-1,568.09%-242.42M43.99%-17.17M-252.54%-17.8M23.75%-91.43M-75.02%-57.91M69.19%-14.53M-26.02%-30.65M
Earnings from equity interest net of tax --055.90%-732K-256.25%-57K83.51%-47K-616.67%-86K62.88%-500K44.83%-1.66M96.53%-16K-326.19%-285K99.28%-12K
Net income 416.86%293.1M-163.58%-356.15M6.45%203.45M16.91%251.41M-526.22%-718.47M-532.78%-92.5M35.02%560.12M102.98%191.12M46.48%215.06M61.40%168.57M
Net income continuous Operations 416.86%293.1M-163.58%-356.15M6.45%203.45M16.91%251.41M-526.22%-718.47M-532.78%-92.5M35.02%560.12M102.98%191.12M46.48%215.06M61.40%168.57M
Minority interest income
Net income attributable to the parent company 416.86%293.1M-163.58%-356.15M6.45%203.45M16.91%251.41M-526.22%-718.47M-532.78%-92.5M35.02%560.12M102.98%191.12M46.48%215.06M61.40%168.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 416.86%293.1M-163.58%-356.15M6.45%203.45M16.91%251.41M-526.22%-718.47M-532.78%-92.5M35.02%560.12M102.98%191.12M46.48%215.06M61.40%168.57M
Basic earnings per share 411.18%4.73-164.46%-5.845.38%3.3318.29%4.14-538.06%-11.74-560.87%-1.5238.32%9.06110.67%3.1650.21%3.564.42%2.68
Diluted earnings per share 391.45%4.43-167.51%-5.843.22%3.2119.30%4.08-571.49%-11.74-560.87%-1.5241.80%8.65119.01%3.1159.81%3.4263.82%2.49
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -